Nextleaf And NOYA Team Up To Launch Cookies ‘C’ Branded Vapes In Canada

Nextleaf Solutions Ltd. (OTCQB: OILFF) (CSE:OILS) (FSE:L0MA) has delivered custom manufactured vape cartridges to NOYA Cannabis Inc. for the Canadian launch of Cookies "C" branded vapes.

Nextleaf Solutions Ltd. (OTCQB:OILFF) (CSE:OILS) (FSE:L0MA) has delivered custom manufactured vape cartridges to NOYA Cannabis Inc. for the Canadian launch of Cookies “C” branded vapes.

Nextleaf is powering NOYA’s launch of “C” branded vape cartridges with four flavors formulated with high-potency distillate produced by Nextleaf’s patented ingredient processing technology. “C” branded vape cartridges are launching first in Ontario, Canada’s largest adult-use cannabis market, this fall.

“The NOYA team has shown an acute eye for identifying powerful brands and have done an excellent job delivering quality flower-based products to market. Naturally, we are excited to leverage the Nextleaf advantage to help power NOYA’s “C” branded vapes in Canada,” stated Ryan Ko, Nextleaf co-founder and V.P. of innovation and technology.

NOYA holds the exclusive rights to premium international brands such as Cookies, Lemonnade, Minntz, and more.

Nextleaf Issues Shares

Nextleaf has issued 100,000 common shares at a deemed price of $0.08 per share for partial conversion of the senior secured convertible note.

Get your daily dose of cannabis news on Benzinga Cannabis. Don’t miss out on any important developments in the industry.

Photo by Jeff W on Unsplash

Related News

Nextleaf Enters New Market Via Atlantic Cultivation

Nextleaf Patents Process For Harvesting Cannabinoids From Waste Biomass While Producing Activated Charcoal

Total
0
Shares
Related Posts
Read More

Altamira Therapeutics’ Peptide-Based Delivery Platform Shown To Enhance Potency Of Commonly Used Gene Delivery Method Published In The Journal Of Integrative Medicine Titled, “Melittin Analog P5RHH Enhances Recombinant Adeno-Associated Virus Transducti…

  Independent peer-reviewed study shows enhanced cell transduction with adeno-associated virus (AAV) vectors, commonly used in gene therapy, when integrating Altamira's peptide-based delivery technology     

CYTO

Read More

‘OpenAI Rival Mistral Nears $2B Valuation With Andreessen Horowitz Backing; French AI Startup Is Set To Raise About €450 Million In Round; Adviser Cedric O Is Among Insiders Set To Sell Partial Stakes’ – Bloomberg News

https://www.bloomberg.com/news/articles/2023-12-04/openai-rival-mistral-nears-2-billion-valuation-with-nvidia-funding Mistral AI is in the final stages of raising roughly €450 million ($487 million) from investors

CRM